Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 2;15(11):2611.
doi: 10.3390/nu15112611.

Serum Essential Elements and Survival after Cancer Diagnosis

Affiliations

Serum Essential Elements and Survival after Cancer Diagnosis

Jan Lubiński et al. Nutrients. .

Abstract

In a prospective study, we measured the associations between three serum elements (Se, Zn and Cu) and the prognosis of 1475 patients with four different types of cancer (breast, prostate, lung and larynx) from University Hospitals in Szczecin, Poland. The elements were measured in serum taken after diagnosis and prior to treatment. Patients were followed from the date of diagnosis until death from any cause or until the last follow-up date (mean years of follow-up: 6.0-9.8 years, according to site). Kaplan-Meier curves were constructed for all cancers combined and for each cancer separately. Age-adjusted hazard ratios (HRs) were estimated using Cox regression. The outcome was all-cause mortality. A Se level in the highest quartile was also associated with a reduced mortality (HR = 0.66; 95%CI 0.49-0.88; p = 0.005) in all-cause mortality for all cancers combined. Zn level in the highest quartile was also associated with reduced mortality (HR = 0.55; 95%CI 0.41-0.75; p = 0.0001). In contrast, a Cu level in the highest quartile was associated with an increase in mortality (HR = 1.91; 95%CI 1.56-2.08; p = 0.0001). Three serum elements-selenium, zinc and copper-are associated with the prognosis of different types of cancer.

Keywords: breast cancer; copper; laryngeal cancer; lung cancer; prostate cancer; selenium; survival; zinc.

PubMed Disclaimer

Conflict of interest statement

Jan Lubiński is the CEO of Read-Gene SA, which offers measurements on a micro-and macroelement level. These authors are part-time employees of Read-Gene: W.M., R.D., C.C., J.G. and T.H. The other authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Five-year survival associated with three element levels in lung cancer subjects; (A) selenium, (B) zinc, (C) copper.
Figure 2
Figure 2
Five-year survival associated with three element levels in larynx cancer subjects; (A) selenium, (B) zinc, (C) copper.
Figure 3
Figure 3
Five-year survival associated with three element levels in breast cancer subjects; (A) selenium, (B) zinc, (C) copper.
Figure 4
Figure 4
Five-year survival associated with three element levels in prostate cancer subjects; (A) selenium, (B) zinc, (C) copper.

Similar articles

Cited by

References

    1. Vella V., Malaguarnera R., Lappano R., Maggiolini M., Belfiore A. Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer. Mol. Cell. Endocrinol. 2017;457:57–72. doi: 10.1016/j.mce.2016.10.020. - DOI - PubMed
    1. Feunteun J., Ostyn P., Delaloge S. Tumor cell malignancy: A complex trait built through reciprocal interactions between tumors and tissue-body system. iScience. 2022;25:104217. doi: 10.1016/j.isci.2022.104217. - DOI - PMC - PubMed
    1. de Jong V.M., Wang Y., ter Hoeve N.D., Opdam M., Stathonikos N., Jóźwiak K., Hauptmann M., Cornelissen S., Vreuls W., Rosenberg E.H., et al. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy. J. Clin. Oncol. 2022;40:2361–2374. doi: 10.1200/JCO.21.01536. - DOI - PMC - PubMed
    1. Sepich-Poore G.D., Zitvogel L., Straussman R., Hasty J., Wargo J.A., Knight R. The microbiome and human cancer. Science. 2021;371:6536. doi: 10.1126/science.abc4552. - DOI - PMC - PubMed
    1. Giannakeas V., Kotsopoulos J., Cheung M.C., Rosella L., Brooks J.D., Lipscombe L., Akbari M.R., Austin P.C., Narod S.A. Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period. JAMA Netw. Open. 2022;5:e2141633. doi: 10.1001/jamanetworkopen.2021.41633. - DOI - PMC - PubMed